Sun Pharmaceutical Industries Ltd. announced that USFDA has granted its subsidiary a tentative approval for an Abbreviated New Drug Application (ANDA) to market a generic version of Cymbalta®, duloxetine hydrochloride delayed-release capsules.
New Compact Digital Retinal Camera From Canon Receives Clearance from FDA
Canon announced last week that its CR-2 Digital Non-Mydriatic Retinal Camera had received 510(k) clearance from the FDA.
New Laser System From OpticaMedica Uses Femto-Second Laser and Optical Coherence Tomography to Perform More Precise Cataract Surgery
OptiMedica Corp. last week announced the results of a clinical study of its Catalys Precision Laser System showing that, when compared to manual techniques, the Catalys Precision Laser System helped surgeons achieve significant improvement in precision during several critical steps of cataract surgery. Catalys is designed to perform four incisions: capsulotomy (a circular incision in […]
New Treatment Targets Natural Tears For Dry Eyes
Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease (“Dry Eye”). RESTASIS® is the first prescription eye drop to ta…
Stargardt Disease To Be Treated With Embryonic Stem Cells in Trial Initiated by Advanced Cell Technology
Earlier this week, Advanced Cell Technology’s request to begin treating patients with Stargardt disease (also known as fundus flavimaculatus) with embryonic stem cells in a clinical trial was approved by the FDA. This will be the second trial using human…
New Treatment Targets Natural Tears For Dry Eyes
Allergan is pleased to announce that Health Canada has approved RESTASIS® (cyclosporine) ophthalmic emulsion, 0.05% w/v for the treatment of moderate to moderately severe Dry Eye disease (“Dry Eye”). RESTASIS® is the first prescription eye drop to ta…